These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 15654813)
21. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas. Ikeda H; Sato N; Matsuura A; Kikuchi K Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386 [TBL] [Abstract][Full Text] [Related]
22. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy. Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735 [TBL] [Abstract][Full Text] [Related]
23. Stimulation of human T cells by an influenza A vector expressing a CTL epitope from the HER-2/neu protooncogene results in higher numbers of antigen-specific TCRhi cells than stimulation with peptide. Divergent roles of IL-2 and IL-15. Efferson CL; Kawano K; Tsuda N; Palese P; García-Sastre A; Ioannides CG Anticancer Res; 2005; 25(2A):715-24. PubMed ID: 15868901 [TBL] [Abstract][Full Text] [Related]
24. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA. Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322 [TBL] [Abstract][Full Text] [Related]
25. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer. Ramanathan S; Gagnon J; Ilangumaran S Arch Immunol Ther Exp (Warsz); 2008; 56(5):311-23. PubMed ID: 18836862 [TBL] [Abstract][Full Text] [Related]
26. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene. Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030 [TBL] [Abstract][Full Text] [Related]
27. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Oelke M; Moehrle U; Chen JL; Behringer D; Cerundolo V; Lindemann A; Mackensen A Clin Cancer Res; 2000 May; 6(5):1997-2005. PubMed ID: 10815925 [TBL] [Abstract][Full Text] [Related]
39. Life or death of T cells with antigen-specific receptors--using T cells for cancer adoptive immunotherapy/gene therapy. Ren-Heidenreich L; Lum LG Curr Gene Ther; 2001 Sep; 1(3):253-5. PubMed ID: 12109140 [TBL] [Abstract][Full Text] [Related]
40. WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells. Stauss HJ; Thomas S; Cesco-Gaspere M; Hart DP; Xue SA; Holler A; King J; Wright G; Perro M; Pospori C; Morris E Blood Cells Mol Dis; 2008; 40(1):113-6. PubMed ID: 17855129 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]